Hepatitis E Virus Drug Development

Hepatitis E virus (HEV) is an underestimated disease, leading to estimated 20 million infections and up to 70,000 deaths annually. Infections are mostly asymptomatic but can reach mortality rates up to 25% in pregnant women or become chronic in immunocompromised patients. The current therapy options...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinast, Volker, Burkard, Thomas L, Todt, Daniel, Steinmann, Eike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631701/
https://www.ncbi.nlm.nih.gov/pubmed/31141919
http://dx.doi.org/10.3390/v11060485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631701/
https://www.ncbi.nlm.nih.gov/pubmed/31141919
http://dx.doi.org/10.3390/v11060485

Ejemplares similares